USE OF POTASSIUM CHANNEL OPENERS FOR THE TREATMENT OF INSULITIS

The present invention relates to the use of potassium channel agonists for the treatment of insulitis associated with various forms of diabetes such as IDDM, NIDDM, SPIDDM (LADA) and gestational diabetes. La présente invention concerne l'utilisation d'agonistes du canal à potassium, pour l...

Full description

Saved in:
Bibliographic Details
Main Authors MICHELSEN, BIRGITTE, KARLSSON, ANDERS, HANSEN, JOHN, BONDO, SANDLER, STELLAN, LI, ZHANCHUN, BJOERK, ELISABETH, KULLIN, MIKAEL, LUND, JESPER, SVENDSTORP
Format Patent
LanguageEnglish
French
Published 03.01.2002
Edition7
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to the use of potassium channel agonists for the treatment of insulitis associated with various forms of diabetes such as IDDM, NIDDM, SPIDDM (LADA) and gestational diabetes. La présente invention concerne l'utilisation d'agonistes du canal à potassium, pour le traitement de l'insulite associée à différentes formes de diabète telles que IDDM, NIDDM, SPIDDM (LADA) et le diabète gestationnel.
Bibliography:Application Number: WO2001DK00444